www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-deSmartHouse Media GmbHhttp://finanzen.net/images/finanzen_net.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_Announces_Results_from_ACP_104_Phase_IIb_Schizophrenia_Trial_741411ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD) today announced results from its Phase IIb trial with ACP-104 for the treatment of schizophrenia. The study did not meet its primary endpoint of antipsychotic efficacy or any of the secondary ...http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_Announces_Results_from_ACP_104_Phase_IIb_Schizophrenia_Trial_741411http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Present_at_Upcoming_Investor_Conferences_736455ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that ...http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Present_at_Upcoming_Investor_Conferences_736455http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Present_at_Upcoming_Investor_Conferences_725187ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that ...http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Present_at_Upcoming_Investor_Conferences_725187http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_Reports_First_Quarter_2008_Financial_Results_719298ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system (CNS) disorders, today reported ...http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_Reports_First_Quarter_2008_Financial_Results_719298http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_Announces_Election_of_Laura_A_Brege_to_Board_of_Directors_719079ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced the ...http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_Announces_Election_of_Laura_A_Brege_to_Board_of_Directors_719079http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Present_at_Upcoming_Investor_Conferences_716933ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that ...http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Present_at_Upcoming_Investor_Conferences_716933http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Announce_First_Quarter_2008_Financial_Results_on_May_5_2008_714795ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that ...http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Announce_First_Quarter_2008_Financial_Results_on_May_5_2008_714795http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Present_Preclinical_Data_on_ACP_104_ACP_105_and_Its_Muscarinic_Discovery_Program_at_Experimental_Biology_2008_Meeting_703530ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that the company will present ...http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Present_Preclinical_Data_on_ACP_104_ACP_105_and_Its_Muscarinic_Discovery_Program_at_Experimental_Biology_2008_Meeting_703530http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_Initiates_Second_Phase_III_Trial_with_Pimavanserin_in_Patients_with_Parkinson_s_Disease_Psychosis_700318ACADIA Pharmaceuticals Inc. (Nasdaq:ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that ...http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_Initiates_Second_Phase_III_Trial_with_Pimavanserin_in_Patients_with_Parkinson_s_Disease_Psychosis_700318http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Present_at_the_8th_Annual_Fortis_Bank_Biotechnology_Conference_699437ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD), a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today announced that ...http://www.finanzen.net/nachricht/ACADIA_Pharmaceuticals_to_Present_at_the_8th_Annual_Fortis_Bank_Biotechnology_Conference_699437